Innospec (NASDAQ:IOSP) Director Larry Padfield Sells 594 Shares

Innospec Inc. (NASDAQ:IOSP) Director Larry Padfield sold 594 shares of Innospec stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $76.56, for a total value of $45,476.64. Following the transaction, the director owned 9,453 shares in the company, valued at approximately $723,721.68. This represents a 5.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Larry Padfield also recently made the following trade(s):

• On Friday, February 20th, Larry Padfield sold 1,030 shares of Innospec stock. The shares were sold at an average price of $81.84, for a total value of $84,295.20.

Innospec Stock Performance

NASDAQ IOSP opened at $76.37 on Wednesday. The stock has a market cap of $1.89 billion, a price-to-earnings ratio of 16.32, a PEG ratio of 2.03 and a beta of 0.90. The business has a 50 day simple moving average of $81.07 and a 200 day simple moving average of $79.08. Innospec Inc. has a 52-week low of $70.10 and a 52-week high of $102.25.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, February 17th. The specialty chemicals company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.24. Innospec had a net margin of 6.56% and a return on equity of 10.18%. The company had revenue of $455.60 million during the quarter, compared to analysts’ expectations of $460.87 million. During the same quarter in the prior year, the company earned $1.41 earnings per share. The business’s quarterly revenue was down 2.4% compared to the same quarter last year. On average, analysts predict that Innospec Inc. will post 6.18 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of IOSP. Geode Capital Management LLC raised its stake in Innospec by 2.1% in the second quarter. Geode Capital Management LLC now owns 719,598 shares of the specialty chemicals company’s stock valued at $60,517,000 after buying an additional 14,463 shares during the period. Westwood Holdings Group Inc. increased its holdings in shares of Innospec by 7.8% during the 2nd quarter. Westwood Holdings Group Inc. now owns 412,310 shares of the specialty chemicals company’s stock worth $34,671,000 after acquiring an additional 29,900 shares during the last quarter. AlphaQuest LLC raised its stake in Innospec by 56.8% in the 3rd quarter. AlphaQuest LLC now owns 45,174 shares of the specialty chemicals company’s stock valued at $3,486,000 after acquiring an additional 16,360 shares during the period. Entropy Technologies LP acquired a new stake in Innospec during the 2nd quarter valued at $873,000. Finally, Public Sector Pension Investment Board boosted its position in Innospec by 14.0% during the third quarter. Public Sector Pension Investment Board now owns 96,866 shares of the specialty chemicals company’s stock worth $7,474,000 after purchasing an additional 11,907 shares during the period. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Wall Street Zen raised shares of Innospec from a “hold” rating to a “buy” rating in a research report on Saturday, December 13th. Weiss Ratings upgraded shares of Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, February 19th. Finally, Zacks Research downgraded Innospec from a “hold” rating to a “strong sell” rating in a research report on Thursday, February 19th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Innospec has an average rating of “Reduce”.

Key Headlines Impacting Innospec

Here are the key news stories impacting Innospec this week:

• Neutral Sentiment: Short-interest update published; may affect near-term trading dynamics depending on whether shorts rose or fell. Short Interest Update
• Negative Sentiment: SVP David B. Jones sold 1,028 shares at an average $75.64 (≈$77.8k); his stake fell ~6.5%. Insider sale disclosed in an SEC filing. David B. Jones Sale
• Negative Sentiment: Director David Landless sold 594 shares at $76.56 (≈$45.5k); his holding dropped ~7.2%. Sale disclosed to the SEC. David Landless Sale
• Negative Sentiment: Director Claudia Poccia sold 119 shares at $76.56 (≈$9.1k); her stake fell ~1.8%. Sale disclosed in an SEC filing. Claudia Poccia SEC Filing
• Negative Sentiment: Director Larry Padfield sold 594 shares at $76.56 (≈$45.5k); his holding fell ~5.9%. Sale disclosed to the SEC. Larry Padfield Sale
• Negative Sentiment: Director Milton C. Blackmore sold 594 shares at $76.56 (≈$45.5k); his position declined ~5.3%. Sale disclosed to the SEC. Milton C. Blackmore Sale

About Innospec

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.